As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/15/20  Precigen, Inc.                    8-K:7,9     1/14/20   11:12M                                    Donnelley … Solutions/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     35K 
 9: R1          Document and Entity Information                     HTML     47K 
 7: XML         IDEA XML File -- Filing Summary                      XML     11K 
 8: XML         XBRL Instance -- d868992d8k_htm                      XML     13K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.LAB  XBRL Labels -- xon-20200114_lab                      XML     53K 
 5: EX-101.PRE  XBRL Presentations -- xon-20200114_pre               XML     34K 
 3: EX-101.SCH  XBRL Schema -- xon-20200114                          XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    18K 
 6: ZIP         XBRL Zipped Folder -- 0001193125-20-007429-xbrl      Zip     18K 

 i INTREXON CORP  i false  i 0001356090 0001356090 2020-01-14 2020-01-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM  i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i January 14, 2020

INTREXON CORPORATION

(Exact name of registrant as specified in its charter)

i Virginia		i 001-36042		i 26-0084895
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 i 20374 Seneca Meadows Parkway,  i Germantown,  i Maryland  i 20876

(Address of principal executive offices) (Zip Code)

 i (301)  i 556-9900

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
i Common Stock, No Par Value		i XON		i Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Item 7.01

Regulation FD Disclosure.

On January 14, 2020, Helen Sabzevari, PhD, President and CEO of Intrexon Corporation, delivered the presentation attached to this current report as Exhibit 99.1 at the 2020 J.P. Morgan Healthcare Conference.

As provided in General Instruction B.2 of Form 8-K, the information in this Item 7.01 and the exhibit furnished hereunder will not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor will they be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as will be expressly set forth by specific reference in such a filing.

Item 9.01

Financial Statements and Exhibits.

(d)        Exhibits.

Exhibit No.				Description
	99.1			Presentation dated January 14, 2020
	104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 14, 2020